Purinergic P2 Receptor Agonists
"Purinergic P2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and stimulate PURINERGIC P2 RECEPTORS.
Descriptor ID |
D058910
|
MeSH Number(s) |
D27.505.519.625.725.200.200 D27.505.696.577.725.200.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Purinergic P2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Purinergic P2 Receptor Agonists".
This graph shows the total number of publications written about "Purinergic P2 Receptor Agonists" by people in this website by year, and whether "Purinergic P2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 | 2007 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Purinergic P2 Receptor Agonists" by people in Profiles.
-
Deterding RR, Lavange LM, Engels JM, Mathews DW, Coquillette SJ, Brody AS, Millard SP, Ramsey BW. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. Am J Respir Crit Care Med. 2007 Aug 15; 176(4):362-9.
-
Song Z, Vijayaraghavan S, Sladek CD. ATP increases intracellular calcium in supraoptic neurons by activation of both P2X and P2Y purinergic receptors. Am J Physiol Regul Integr Comp Physiol. 2007 Jan; 292(1):R423-31.
-
Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, Mathews D, Gorden J, Schaberg A, Williams J, Ramsey B. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonol. 2005 Apr; 39(4):339-48.
-
Kapoor JR, Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci. 2000 Dec 01; 20(23):8868-75.
-
Nandanan E, Camaioni E, Jang SY, Kim YC, Cristalli G, Herdewijn P, Secrist JA, Tiwari KN, Mohanram A, Harden TK, Boyer JL, Jacobson KA. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem. 1999 May 06; 42(9):1625-38.
-
Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, Boyer JL, King BF, Burnstock G. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. J Med Chem. 1998 Jun 18; 41(13):2201-6.
|
People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|